Rockwell Medical Inc - Asset Resilience Ratio
Rockwell Medical Inc (RMTI) has an Asset Resilience Ratio of 25.26% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Rockwell Medical Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Rockwell Medical Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Rockwell Medical Inc (RMTI) total assets.
Liquid Assets Composition Over Time
This chart breaks down Rockwell Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Rockwell Medical Inc (RMTI) financial obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $14.28 Million | 25.26% |
| Total Liquid Assets | $14.28 Million | 25.26% |
Asset Resilience Insights
- Very High Liquidity: Rockwell Medical Inc maintains exceptional liquid asset reserves at 25.26% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Rockwell Medical Inc Industry Peers by Asset Resilience Ratio
Compare Rockwell Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 4.31% |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723 |
Drug Manufacturers - Specialty & Generic | 1.01% |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
Drug Manufacturers - Specialty & Generic | 5.90% |
Annual Asset Resilience Ratio for Rockwell Medical Inc (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Rockwell Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 25.00% | $14.29 Million | $57.15 Million | +14.97pp |
| 2024-12-31 | 10.03% | $5.94 Million | $59.21 Million | +6.29pp |
| 2023-12-31 | 3.74% | $1.95 Million | $52.17 Million | -20.68pp |
| 2022-12-31 | 24.42% | $11.39 Million | $46.63 Million | +5.57pp |
| 2021-12-31 | 18.85% | $9.16 Million | $48.57 Million | +6.00pp |
| 2020-12-31 | 12.86% | $10.00 Million | $77.75 Million | -19.30pp |
| 2019-12-31 | 32.15% | $14.25 Million | $44.32 Million | +11.57pp |
| 2018-12-31 | 20.58% | $10.82 Million | $52.56 Million | -21.35pp |
| 2017-12-31 | 41.93% | $24.65 Million | $58.78 Million | -7.08pp |
| 2016-12-31 | 49.02% | $40.76 Million | $83.15 Million | +4.06pp |
| 2015-12-31 | 44.96% | $39.48 Million | $87.82 Million | +24.62pp |
| 2014-12-31 | 20.33% | $19.93 Million | $98.00 Million | -12.76pp |
| 2013-12-31 | 33.10% | $12.03 Million | $36.36 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $17.03 Million | -- |
| 2011-12-31 | 36.98% | $11.81 Million | $31.94 Million | +4.68pp |
| 2010-12-31 | 32.29% | $11.94 Million | $36.97 Million | +32.18pp |
| 2004-12-31 | 0.12% | $9.00K | $7.70 Million | -0.01pp |
| 2003-12-31 | 0.13% | $9.00K | $7.04 Million | -0.09pp |
| 2002-12-31 | 0.22% | $14.00K | $6.45 Million | -4.62pp |
| 2001-12-31 | 4.84% | $293.00K | $6.06 Million | +1.13pp |
| 2000-12-31 | 3.70% | $150.00K | $4.05 Million | -- |
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more